42 U.S.C. 282: Director of National Institutes of Health

2025

• Pub. L. 118–228, §3(b), inserted "and shall prioritize, as appropriate, such pediatric research that does not duplicate existing research activities of the National Institutes of Health" before "; and". Law text · (b)
• Pub. L. 118–228, §2(3), substituted "the Division of Program Coordination, Planning, and Strategic Initiatives" for "the Common Fund". Law text · (b)

2022

• Pub. L. 117–286 substituted "Chapter 10 of title 5" for "The Federal Advisory Committee Act" in concluding provisions. Law text · (b)
• Pub. L. 117–328, §2302, added par. (26). (Consolidated Appropriations Act, 2023) Law text · (b)
• Pub. L. 117–328, §2323, added pars. (27) to (29). (Consolidated Appropriations Act, 2023) Law text · (b)

2021

• Pub. L. 117–15 added subsec. (o). Law text · (o)

2018

• Pub. L. 115–271 added subpar. (C). (Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment for Patients and Communities Act" or the "SUPPORT for Patients and Communities Act) Law text · (n)

2016

• Pub. L. 114–255, §2038(a)(1), amended par. (4) generally. Prior to amendment, text read as follows: "shall assemble accurate data to be used to assess research priorities, including information to better evaluate scientific opportunity, public health burdens, and progress in reducin… (21st Century Cures Act) Law text · (b)
• Pub. L. 114–255, §2031(a)(1), inserted ", and through the development, implementation, and updating of the strategic plan developed under subsection (m)" before semicolon. (21st Century Cures Act) Law text · (b)
• Pub. L. 114–255, §2038(a)(2), added subpars. (C) and (D). (21st Century Cures Act) Law text · (b), (D)
• Pub. L. 114–255, §2014(a), added par. (25). (21st Century Cures Act) Law text · (b)
• Pub. L. 114–255, §2051(1), inserted ", unless the responsible party affirmatively requests that the Director of the National Institutes of Health publicly post such clinical trial information for an applicable device clinical trial prior to such date of clearance or approv… (21st Century Cures Act) Law text · (j)
• Pub. L. 114–255, §2051(2), added cls. (iii) and (iv). (21st Century Cures Act) Law text · (j), (iv)
• Pub. L. 114–255, §2031(a)(2), added subsec. (m). (21st Century Cures Act) Law text · (m)
• Pub. L. 114–255, §2036(a), added subsec. (n). (21st Century Cures Act) Law text · (n)

2014

• Pub. L. 113–94 amended par. (7) generally, enacting similar provisions and adding provisions relating to allocating funds appropriated pursuant to section 282a(a)(2) of this title for making grants for pediatric research. Law text · (b)

2011

• Pub. L. 112–74, §221(d)(1), substituted "287a" for "282d". (Consolidated Appropriations Act, 2012) Law text · (b)
• Pub. L. 112–74, §221(b)(5)(B), redesignated and transferred subsec. (g) of this section to subsec. (b) of section 285k of this title. (Consolidated Appropriations Act, 2012) Law text · (g)

2010

• Pub. L. 111–148 added par. (24). (Patient Protection and Affordable Care Act) Law text · (b)

2008

• Pub. L. 110–316, §302(1), in introductory provisions, substituted "for each applicable clinical trial for a drug that is approved under section 355 of title 21 or licensed under section 262 of this title or a device that is cleared under section 360(k) of title 21 or approved und… Law text · (j)
• Pub. L. 110–316, §302(2), substituted "applicable clinical trials described in subparagraph (C)" for "drugs described in subparagraph (C)". Law text · (j), (iii)

2007

• Pub. L. 109–482, §102(f)(1)(A), substituted "Director of NIH who shall" for "Director of the National Institutes of Health (hereafter in this subchapter referred to as the 'Director of NIH') who shall". (National Institutes of Health Reform Act of 2006) Law text · (a)
• Pub. L. 109–482, §102(a)(5), substituted "paragraph (16)" for "paragraph (6)" in concluding provisions. (National Institutes of Health Reform Act of 2006) Law text · (b)
• Pub. L. 109–482, §102(a)(6), added par. (1) and struck out former par. (1) which read as follows: "shall be responsible for the overall direction of the National Institutes of Health and for the establishment and implementation of general policies respecting the management and opera… (National Institutes of Health Reform Act of 2006) Law text · (b)
• Pub. L. 109–482, §102(b), added pars. (2) and (3) and struck out former pars. (2) and (3) which read as follows: (National Institutes of Health Reform Act of 2006) Law text · (b), (3)
• Pub. L. 110–85, §1104(2), inserted "minority and other" after "reducing". (Food and Drug Administration Amendments Act of 2007) Law text · (b)
• Pub. L. 109–482, §102(b), added par. (4). Former par. (4) redesignated (14). (National Institutes of Health Reform Act of 2006) Law text · (b)
• Pub. L. 109–482, §102(a)(1)–(4), (b), added pars. (5) to (13), redesignated former pars. (4) to (11) and (14) as (14) to (22), respectively, in par. (21) inserted "and" at end, and struck out former pars. (12) and (13) which read as follows: (National Institutes of Health Reform Act of 2006) Law text · (b)
• Pub. L. 110–85, §304(a), added par. (23). (Food and Drug Administration Amendments Act of 2007) Law text · (b)
• Pub. L. 109–482, §102(c), redesignated subsec. (j) as (i) and struck out former subsec. (i) which related to discretionary fund for use by the Director of NIH to carry out activities authorized in this chapter. (National Institutes of Health Reform Act of 2006) Law text · (i)
• Pub. L. 109–482, §103(b)(1), struck out first sentence which read as follows: "For the purpose of carrying out this subsection, there are authorized to be appropriated such sums as may be necessary." (National Institutes of Health Reform Act of 2006) Law text · (i)
• Pub. L. 110–85, §801(a), added subsec. (j) and redesignated former subsec. (j) as (k). Former subsec. (k) redesignated (l). (Food and Drug Administration Amendments Act of 2007) Law text · (j), (k)
• Pub. L. 109–482, §102(c)(2), (d), added subsec. (k) and redesignated former subsec. (k) as (j). (National Institutes of Health Reform Act of 2006) Law text · (j), (k)
• Pub. L. 110–85, §801(a)(1), redesignated subsec. (k) as (l). (Food and Drug Administration Amendments Act of 2007) Law text · (l)
• Pub. L. 109–482, §102(c)(1), struck out subsec. (l) which read as follows: "The Director of NIH shall carry out the program established in part F of subchapter X of this chapter (relating to interagency research on trauma)." (National Institutes of Health Reform Act of 2006) Law text · (l)

2002

• Pub. L. 107–109, which directed the amendment of the first sentence of subsec. (j)(3)(A) by substituting "trial sites," for "trial sites, and" and "in the trial, and a description of whether, and through what procedure, the manufacturer or sponsor of the investigation of a new dr… (Best Pharmaceuticals for Children Act) Law text · (j)

1998

• Pub. L. 105–392 added pars. (13) and (14). (Health Professions Education Partnerships Act of 1998) Law text · (b), (14)
• Pub. L. 105–362 inserted "and" at end of par. (1), substituted a period for "; and" at end of par. (2), and struck out par. (3) which read as follows: "annually prepare and submit to the Director of NIH a report concerning the prevention and dissemination activities undertaken by the A… (Federal Reports Elimination Act of 1998) Law text · (f)

1997

• Pub. L. 105–115 added subsec. (j) and redesignated former subsecs. (j) and (k) as (k) and (l), respectively. (Food and Drug Administration Modernization Act of 1997) Law text · (j), (k), (l)

1993

• Pub. L. 103–43, §141(b), added par. (12). · (b)
• Pub. L. 103–43, §210(b), added par. (5). · (e)
• Pub. L. 103–43, §201, substituted "other public and private entities, including elementary, secondary, and post-secondary schools. The Associate Director shall—" and pars. (1) to (3) for "other public and private entities. The Associate Director shall annually report to the Director of… · (f)
• Pub. L. 103–43, §202, added subsec. (g). · (g)
• Pub. L. 103–43, §206, added subsec. (h). · (h)
• Pub. L. 103–43, §208, added subsec. (i). · (i)
• Pub. L. 103–43, §210(c), added subsec. (j). · (j)
• Pub. L. 103–43, §303(b), added subsec. (k). · (k)

1992

• Pub. L. 102–321 substituted "220" for "two hundred". · (d)

1988

• Pub. L. 100–607 inserted "and scientific program advisory committees" after "peer review groups". · (b)